Literature DB >> 9579129

Protocol violation in deep vein thrombosis prophylaxis.

B D George1, T A Cook, I J Franklin, J Nethercliff, R B Galland.   

Abstract

This study aimed to determine how closely deep vein thrombosis (DVT) prophylactic policies are adhered to in routine general surgical practice, to identify reasons for policy violations and to assess the effects of policy modification. Eight adult patients, sixty of whom had undergone an operation, under the care of six general surgeons, each with their own written DVT protocol, were studied on one weekday. Thirty patients (50%) did not receive DVT prophylaxis according to the policy of the relevant consultant. Most violations occurred for unacceptable reasons, mainly starting low-dose subcutaneous heparin or using thromboembolic stockings postoperatively. However, 43% of protocol violations occurred for acceptable clinical reasons. Following the initial study, a uniform departmental DVT prophylaxis policy was introduced. Nursing and medical staff were thoroughly appraised of the new policy. In a repeat study of 75 patients 1 year later, there were 15 protocol violations among 58 patients who had undergone an operation (27%). However, there were no violations for acceptable reasons. The number of unacceptable protocol violations in the two studies was similar (24/60 and 17/56). The number of patients at moderate or high DVT risk who received no preoperative prophylaxis was the same in both studies (8/48 in both audits). DVT protocol violations are common in routine general surgical practice. Policy modification and unification results in fewer violations, but made little impact on the level of thromboprophylactic care.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579129      PMCID: PMC2502760     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  6 in total

1.  Improving uptake of prophylaxis for venous thromboembolism in general surgical patients using prospective audit.

Authors:  G J Byrne; M J McCarthy; S H Silverman
Journal:  BMJ       Date:  1996-10-12

Review 2.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

Authors:  R Collins; A Scrimgeour; S Yusuf; R Peto
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

3.  Clinical guidelines and the law.

Authors:  B Hurwitz
Journal:  BMJ       Date:  1995-12-09

4.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

Authors:  J M Grimshaw; I T Russell
Journal:  Lancet       Date:  1993-11-27       Impact factor: 79.321

5.  Administration of heparin and antibiotic prophylaxis.

Authors:  C M Avery; N V Jamieson; R Y Calne
Journal:  Br J Surg       Date:  1994-07       Impact factor: 6.939

6.  The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis.

Authors:  A Allan; J T Williams; J P Bolton; L P Le Quesne
Journal:  Br J Surg       Date:  1983-03       Impact factor: 6.939

  6 in total
  4 in total

1.  Deep vein thrombosis prophylaxis protocol--needs active enforcement.

Authors:  A Huang; N Barber; A Northeast
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

Review 2.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

3.  Use of a thromboembolic risk score to improve thromboprophylaxis in surgical patients.

Authors:  G Harinath; P H St John
Journal:  Ann R Coll Surg Engl       Date:  1998-09       Impact factor: 1.891

4.  Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study.

Authors:  Antonio Vallano; Josep Maria Arnau; Gaietà Permanyer Miralda; Jaume Pérez-Bartolí
Journal:  Thromb J       Date:  2004-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.